DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14

Estella A Koppel1, Eirikur Saeland, Désirée J M de Cooker

  • 1Department of Molecular Cell Biology & Immunology, VU University Medical Center Amsterdam, v.d. Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.

Immunobiology
|September 17, 2005
PubMed

Insights

Dendritic cell-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN) specifically binds Streptococcus pneumoniae serotypes 3 and 14. This interaction, though not immunomodulatory, offers potential for novel vaccine development against pneumococcal disease.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Streptococcus pneumoniae causes community-acquired pneumonia and antibiotic resistance is increasing.
  • Understanding host-pathogen interactions is crucial for effective treatment and vaccine development.
  • Dendritic cells (DCs) use receptors like DC-SIGN for pathogen recognition, a key step in immune response induction.

Purpose of the Study:

  • To investigate the in vitro binding of DC-SIGN with Streptococcus pneumoniae.
  • To identify specific S. pneumoniae serotypes that interact with DC-SIGN.
  • To explore the potential implications of DC-SIGN interaction in pneumococcal pathogenesis and vaccine strategies.

Main Methods:

  • In vitro binding assays were performed to assess the interaction between DC-SIGN and various S. pneumoniae serotypes.
  • Ligand identification for DC-SIGN binding was explored, focusing on capsular polysaccharides.
  • Immunomodulatory effects of the interaction on dendritic cells were evaluated.

Main Results:

  • DC-SIGN specifically binds to S. pneumoniae serotypes 3 and 14, but not to serotype 19F.
  • Binding to serotype 14 involves a ligand expressed by the capsular polysaccharide.
  • Binding to serotype 3 involves an unidentified ligand.
  • No immunomodulatory effects on dendritic cells were observed despite the binding of S. pneumoniae serotype 14 to DC-SIGN.

Conclusions:

  • DC-SIGN exhibits serotype-specific binding to Streptococcus pneumoniae.
  • The interaction mechanism for serotype 3 binding requires further elucidation.
  • While direct immunomodulation was not observed, the serotype-specific interaction with DC-SIGN warrants further investigation for potential vaccine development against pneumococcal infections.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...